TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04211064

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Ultrasonographic measurement of optic nerve sheath diameter
Description: Optic nerve sheath diameter will be measured at both neuromuscular blocks level.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasonographic measurement of optic nerve sheath diameter
Description: Optic nerve sheath diameter will be measured at both neuromuscular blocks level.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Deep neuromuscular block
Description: Deep neuromuscular block will be obtained via appropriate dose of rocuronium.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Moderate neuromuscular block
Description: Moderate neuromuscular block will be obtained via appropriate dose of rocuronium.
Study: NCT05015816

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Total body photography
Description: 3 monthly TBP imaging
Study: NCT04423822

Intervention type: OTHER
Intervention: stress test
Description: endurance capacity
Study: NCT04230421

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Monsenso system with feedback
Description: See description under intervention

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: The Monsenso system without feedback
Description: See description under intervention

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CAG Bipola and mood monitoring only
Description: See description under intervention
Study: NCT05180292

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5 MG
Description: Carvedilol 12.5 mg
Study: NCT06256289

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100mg Tab
Description: Canagliflozin 100mg once daily combined Metformin 1000mg twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hydrochloride
Description: Metformin 1000mg twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin Hydrochloride
Description: Metformin 1000mg twice daily
Study: NCT06350890

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HTD1801
Description: HTD1801 1000 mg administered orally BID as four capsules

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo administered orally BID as four capsules
Study: NCT05166941

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: creative drama
Description: In the training program, a total of six games were played about the experiences of psychiatric patients. The program was designed to be two game per week for four weeks.
Study: NCT05606757

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX Dose A
Description: Injection; intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX Dose A
Description: Injection; intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX Dose A
Description: Injection; intramuscular

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for BOTOX
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for BOTOX
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo for BOTOX
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX Dose B
Description: Injection; intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX Dose B
Description: Injection; intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX Dose B
Description: Injection; intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX Dose C
Description: Injection; intramuscular

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOTOX Dose C
Description: Injection; intramuscular
Study: NCT04887025

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RGV004
Description: a genetically-engineered vaccinia virus (encoding CD19/CD3 bispecific antibody)
Study: NCT06423040

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Social Media Chatbot on Physical Activity Education
Description: a social media chatbot was used to provide a continuous and real-time multimedia health education program on physical activity for the older adults, as well as supportive messages and feedbacks.
Study: NCT05897255

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Surface EMG Biofeedback
Description: Surface EMG activity will be recorded from the left and right abdominal muscles while the exercises will be performed in different positions. Electrical signals in the muscle are measured and displayed on the screen and are amplified into sounds that the patient can hear. This feedback increases patient effort and participation and provides the data and documentation required to measure patient outcomes and quantify progress. Electrical activity from Rectus Abdominis muscle, External Oblique muscle and Transversus Abdominis muscle will be recorded with their specific exercises. SEMG Biofeedback protocol of a series of ten second contractions, each contraction preceded by a ten second rest period will be followed. Starting with shorter work/rest periods as needed to build-up to these intervals are acceptable; for example, starting with 3-second contractions and 6-second rest periods, and then gradually increasing the duration of each.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surface EMG Biofeedback
Description: Surface EMG activity will be recorded from the left and right abdominal muscles while the exercises will be performed in different positions. Electrical signals in the muscle are measured and displayed on the screen and are amplified into sounds that the patient can hear. This feedback increases patient effort and participation and provides the data and documentation required to measure patient outcomes and quantify progress. Electrical activity from Rectus Abdominis muscle, External Oblique muscle and Transversus Abdominis muscle will be recorded with their specific exercises. SEMG Biofeedback protocol of a series of ten second contractions, each contraction preceded by a ten second rest period will be followed. Starting with shorter work/rest periods as needed to build-up to these intervals are acceptable; for example, starting with 3-second contractions and 6-second rest periods, and then gradually increasing the duration of each.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surface EMG Biofeedback
Description: Surface EMG activity will be recorded from the left and right abdominal muscles while the exercises will be performed in different positions. Electrical signals in the muscle are measured and displayed on the screen and are amplified into sounds that the patient can hear. This feedback increases patient effort and participation and provides the data and documentation required to measure patient outcomes and quantify progress. Electrical activity from Rectus Abdominis muscle, External Oblique muscle and Transversus Abdominis muscle will be recorded with their specific exercises. SEMG Biofeedback protocol of a series of ten second contractions, each contraction preceded by a ten second rest period will be followed. Starting with shorter work/rest periods as needed to build-up to these intervals are acceptable; for example, starting with 3-second contractions and 6-second rest periods, and then gradually increasing the duration of each.
Study: NCT05959343

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery program for Oblique Lumbar Interbody Fusion
Description: In the ERAS CP group, the components of the ERAS are protocolized and implemented as a clinical pathway
Study: NCT06318325

Intervention type: DIAGNOSTIC_TEST
Intervention: examination
Description: examination of tendon, muscle joints and injuries
Study: NCT05692505

Intervention type: DIAGNOSTIC_TEST
Intervention: QuadQuik
Description: Invitro diagnostic device

Intervention type: DIAGNOSTIC_TEST
Intervention: QuadQuik
Description: Invitro diagnostic device
Study: NCT06069050

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: sequential adolesent left lateral lobe liver transplantation (SALT)
Description: Hemihepatectomy combined with left lateral lobe liver transplantation was performed first, and residual liver resection was performed after the graft grew to a sufficient functional liver volume.
Study: NCT05174663

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Almond-enriched diet - 1.5 oz
Description: Participants will receive 1.5 oz of almonds consumed as a snack daily for 16 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Almond-enriched diet - 2.5 oz
Description: Participants will receive 2.5 oz of almonds consumed as a snack daily for 16 weeks.

Intervention type: OTHER
Group type: OTHER
Intervention: Control snack
Description: Participants will receive a control snack daily for 16 weeks.
Study: NCT05788302

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure
Description: - Participation will occur throughout 17 weeks over 15 separate visits during which 10, 60-minute sessions of PE will take place. Session 1 of PE will focus on psychoeducation. Session 2 of PE will involve a continuation of psychoeducation and rationale for exposure as well as the collaborative construction of the in vivo exposure hierarchy. After session 2, participants will begin homework where they are instructed to confront situations on their hierarchy. Starting in session 3 of PE, participants will begin imaginal exposures to their worst trauma memory. This involves the participant recounting and visualizing the trauma memory aloud with the clinician in the room for 30-40 minutes. The session will end with 15-20 minutes of processing the imaginal exposure. Participants will continue in-session imaginal exposures until the end of treatment. Throughout the treatment, participants will listen to a recording of their imaginal exposure and engage in in vivo exposures daily.
Study: NCT05378243

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Gait Training
Description: Use of a walker adapted with robotic components to promote proper walking gait

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Functional Clinical Therapy
Description: Personalized program of physical therapy targeted to improving walking gait
Study: NCT05140330

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALAPAGE workshop
Description: 7 weekly group sessions over 2 months (1 introduction session, 2 physical activity sessions and 4 nutrition sessions) and 1 evaluation session at 3 months

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: control workshop
Description: 3 evaluation group sessions over 2 months and 1 session at 3 months. After those 4 sessions, the participants will benefit from an ALAPAGE workshop
Study: NCT04595721

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hidden object
Description: Participant will be instructed to look at the hidden object image on the overhead light to look for a number of objects and observe the image.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stress ball
Description: Participants will be handed a single-use, squeezable stress ball and instructed to squeeze the stress ball.
Study: NCT05421338

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 456906 (C-14)
Description: BI 456906 (C-14)
Study: NCT05602545

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: food consumption in periodontal health and disease
Description: To determine individuals' daily energy and nutrient intakes and the consumption amounts of food groups, food consumption records were kept by the nutritionist for three consecutive days, with one of them was weekend, using the 24-hour recall method. Data on individuals' frequency and amount of consumption of some fermented products were recorded, considering the foods available in our culture and the market.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: food consumption in periodontal health and disease
Description: To determine individuals' daily energy and nutrient intakes and the consumption amounts of food groups, food consumption records were kept by the nutritionist for three consecutive days, with one of them was weekend, using the 24-hour recall method. Data on individuals' frequency and amount of consumption of some fermented products were recorded, considering the foods available in our culture and the market.

Intervention type: OTHER
Group type: OTHER
Intervention: food consumption in periodontal health and disease
Description: To determine individuals' daily energy and nutrient intakes and the consumption amounts of food groups, food consumption records were kept by the nutritionist for three consecutive days, with one of them was weekend, using the 24-hour recall method. Data on individuals' frequency and amount of consumption of some fermented products were recorded, considering the foods available in our culture and the market.
Study: NCT05063214

Intervention type: DIAGNOSTIC_TEST
Intervention: Muscle ultrasound evaluation
Description: Muscle ultrasound evaluation will be performed in patients admitted with COVID-19 requiring invasive mechanical ventilation. The measurements of thickness and thickening fraction will occur for diaphragm, abdominal - rectus abdominis, internal oblique, external oblique and transverse abdomen - and parasternal intercostal muscles. Serial measurements of the thickness and echogenicity of the quadriceps femoris muscle will also be performed.
Study: NCT05484388

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SN2
Description: Investigational device absorption level Normal

Intervention type: DEVICE
Group type: OTHER
Intervention: SN2
Description: Investigational device absorption level Normal

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SP3
Description: Investigational device absorption level Plus

Intervention type: DEVICE
Group type: OTHER
Intervention: SP3
Description: Investigational device absorption level Plus
Study: NCT05403190

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: da Vinci SP system
Description: using da Vinci SP system to perform extraperitoneal approach radical prostatectomy
Study: NCT05477732

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum OLP-01
Description: Bifidobacterium longum OLP-01 is one of probiotics. Subjects in OLP-01 group will supplement with either 2 × 1010 colony-forming unit (CFU) of Bifidobacterium longum OLP-01 powder per day for 12 weeks.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects in placebo group will supplement with placebo powder per day for 12 weeks.
Study: NCT05225064

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incentives to be vaccinated
Description: Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incentives to be vaccinated
Description: Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mask
Description: Individuals are given cloth masks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Encouragement to wear a mask
Description: Individuals who are not wearing masks over their mouth and nose are stopped in public places and encouraged to wear a mask

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vaccination made more convenient
Description: Vaccines are conducted at the household-level rather than the village-level

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vaccination made more convenient
Description: Vaccines are conducted at the household-level rather than the village-level

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vaccination made more convenient
Description: Vaccines are conducted at the household-level rather than the village-level

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vaccination made more convenient
Description: Vaccines are conducted at the household-level rather than the village-level

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social mobilization campaign to be vaccinated
Description: Village-level social mobilization campaign to be vaccinated

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social mobilization campaign to be vaccinated
Description: Village-level social mobilization campaign to be vaccinated

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social mobilization campaign to be vaccinated
Description: Village-level social mobilization campaign to be vaccinated

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social mobilization campaign to be vaccinated
Description: Village-level social mobilization campaign to be vaccinated
Study: NCT05862922

Intervention type: DEVICE
Intervention: Analgesia Nosiception İndex Monitoring
Description: ANI is a monitor that can be measured continuously and non-invasively. It measures parasympathetic tone - based on electrocardiography - by analyzing minimal changes in heart rate that occur under anesthesia, in the early stages of awakening, and in each respiratory cycle of awake patients. At the end of the measurement, a value between 0-100 is obtained.~Parasympathetic modulation (stress level, e.g., pain) is obtained with a minimum value of 0 and a maximum of 100. ANI values measured in the early period of recovery correlate with pain scores. When compared with hemodynamic parameters, it has been reported that the ANI response is more sensitive to nociceptive stimuli occurring in the intraoperative period.

Intervention type: DEVICE
Intervention: Analgesia Nosiception İndex Monitoring
Description: ANI is a monitor that can be measured continuously and non-invasively. It measures parasympathetic tone - based on electrocardiography - by analyzing minimal changes in heart rate that occur under anesthesia, in the early stages of awakening, and in each respiratory cycle of awake patients. At the end of the measurement, a value between 0-100 is obtained.~Parasympathetic modulation (stress level, e.g., pain) is obtained with a minimum value of 0 and a maximum of 100. ANI values measured in the early period of recovery correlate with pain scores. When compared with hemodynamic parameters, it has been reported that the ANI response is more sensitive to nociceptive stimuli occurring in the intraoperative period.
Study: NCT01511822

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Drospirenone Ethinyl estradiol
Description: Drospirenone 3mg/die Ethinyl estradiol 30 mg/die (21 days/month for 6 months)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drospirenone Ethinyl estradiol Myo-inositol
Description: Drospirenone 3mg/die Ethinyl estradiol 30 mg/die (21 days/months for 6 months) + Myo-inositol 6g /die for 6 months

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study: NCT05871710

Intervention type: OTHER
Intervention: Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale
Description: The Tele-Pulmonary Rehabilitation Acceptance Scale is a measuring tool that assesses the level of acceptance towards telerehabilitation programs among healthcare providers and patients in the field of pulmonary rehabilitation. It is used to evaluate the attitudes, beliefs, and perceptions of potential users towards telerehabilitation, which is a form of healthcare delivery that utilizes telecommunication technology to provide remote rehabilitation services to patients. The scale is intended to provide a standardized data collection tool that can be used to measure the level of acceptance of telerehabilitation programs among different groups of potential users. This scale will be translated into Turkish by a researcher who has an advanced level of knowledge in English and whose native language is Turkish.

Intervention type: OTHER
Intervention: Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale
Description: The Tele-Pulmonary Rehabilitation Acceptance Scale is a measuring tool that assesses the level of acceptance towards telerehabilitation programs among healthcare providers and patients in the field of pulmonary rehabilitation. It is used to evaluate the attitudes, beliefs, and perceptions of potential users towards telerehabilitation, which is a form of healthcare delivery that utilizes telecommunication technology to provide remote rehabilitation services to patients. The scale is intended to provide a standardized data collection tool that can be used to measure the level of acceptance of telerehabilitation programs among different groups of potential users. This scale will be translated into Turkish by a researcher who has an advanced level of knowledge in English and whose native language is Turkish.

Intervention type: OTHER
Intervention: Scale Evaluation Form
Description: The healthcare providers and the patients will be asked about their opinions on the scale's construction, usefulness, and scope using a 100 mm visual analog scale.

Intervention type: OTHER
Intervention: Scale Evaluation Form
Description: The healthcare providers and the patients will be asked about their opinions on the scale's construction, usefulness, and scope using a 100 mm visual analog scale.
Study: NCT06624319

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine as adjuvent to bupvacaine in tap block
Description: The analgesic effect of Two different doses of dexmedetomidine as adjuvent to bupivacaine in tap block

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine as adjuvent to bupvacaine in tap block
Description: The analgesic effect of Two different doses of dexmedetomidine as adjuvent to bupivacaine in tap block
Study: NCT05047874

Intervention type: BEHAVIORAL
Intervention: systemic methylprednisolone
Description: short-term (3 days) high-dose (1000 mg) systemic methylprednisolone and low-dose long-term (2x 40 mg) systemic methylprednisolone

Intervention type: BEHAVIORAL
Intervention: systemic methylprednisolone
Description: short-term (3 days) high-dose (1000 mg) systemic methylprednisolone and low-dose long-term (2x 40 mg) systemic methylprednisolone
Study: NCT06168812

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glipizide
Description: The therapeutic intervention in this study involves the sulfonylurea glipizide in ER formulation.
Study: NCT05604924

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: virtual reality training for cesarean section
Description: Participants who received virtual reality training for cesarean section can learn the surgical procedures as if they were in a real field.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: virtual reality training for cesarean section
Description: Participants who received virtual reality training for cesarean section can learn the surgical procedures as if they were in a real field.